Neuroprotection and functional recovery conferred by administration of kappa- and delta1-opioid agonists in a rat model of global ischemia

Physiology and Behavior

Volumn 93, Issue 3, 2008, Pages 502-511

  Charron, Charlaine ^a   Messier, Claude ^a   Plamondon, Hélène ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

488H; Behavioral hyperactivity; CA1; DPDPE; Global ischemia; Hippocampus; Neuronal protection; Rats; Spatial memory; U50

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; SODIUM CHLORIDE;

AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BLOOD VESSEL OCCLUSION; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPAL DAMAGE; LOCOMOTION; MALE; MAZE TEST; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

EID: 38849095818     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.10.015     Document Type: Article

References (63)

1. Hall E.D., and Pazara K.E. Quantitative analysis of effects of kappa-opioid agonists on postischemic hippocampal CA1 neuronal necrosis in gerbils. Stroke 19 (1988) 1008-1012
2. Contreras P.C., Ragan D.M., Bremer M.E., Lanthorn T.H., Gray N.M., Iyengar S., et al. Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil. Brain Res 546 (1991) 79-82
3. Kusumoto K., MacKay K.B., and McCulloch J. The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia. Brain Res 576 (1992) 147-151
4. Itoh J., Ukai M., and Kameyama T. U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice. Brain Res 619 (1993) 223-228
5. Ohno M., Yamamoto T., and Ueki S. Effect of the kappa-receptor agonist, U-50,488H, on cerebral ischemia-induced impairment of working memory assessed in rats by a three-panel runway task. Eur J Pharmacol 193 (1991) 357-361
6. Birch P.J., Rogers H., Hayes A.G., Hayward N.J., Tyers M.B., Scopes D.I., et al. Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist. Br J Pharmacol 103 (1991) 1819-1823
7. Chen T.Y., Goyagi T., Toung T.J., Kirsch J.R., Hurn P.D., Koehler R.C., et al. Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats. Stroke 35 (2004) 1180-1185
8. Corbett D., and Nurse S. The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog Neurobiol 54 (1998) 531-548
9. Von Voigtlander P.F., and Lewis R.A. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists. Prog Neuropsychopharmacol Biol Psychiatry 6 (1982) 467-470
10. Clark J.A., and Pasternak G.W. U50,488: a kappa-selective agent with poor affinity for mu1 opiate binding sites. Neuropharmacology 27 (1988) 331-332
11. Tang A.H. Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent. Life Sci 37 (1985) 1475-1482
12. Bolling S.F., Badhwar V., Schwartz C.F., Oeltgen P.R., Kilgore K., and Su T.P. Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists. J Thorac Cardiovasc Surg 122 (2001) 476-481
13. Bofetiado D.M., Mayfield K.P., and D'Alecy L.G. Alkaloid delta agonist BW373U86 increases hypoxic tolerance. Anesth Analg 82 (1996) 1237-1241
14. Romano M.A., Seymour E.M., Berry J.A., McNish R.A., and Bolling S.F. Relative contribution of endogenous opioids to myocardial ischemic tolerance. J Surg Res 118 (2004) 32-37
15. Schultz J.E., Hsu A.K., and Gross G.J. Ischemic preconditioning in the intact rat heart is mediated by delta1-but not mu- or kappa-opioid receptors. Circulation 97 (1998) 1282-1289
16. Okubo S., Tanabe Y., Takeda K., Kitayama M., Kanemitsu S., Kukreja R.C., et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor. Am J Physiol Heart Circ Physiol 287 (2004) H1786-H1791
17. Weinbrenner C., Schulze F., Sarvary L., and Strasser R.H. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res 61 (2004) 591-599
18. Watson M.J., Holt J.D., O'neill S.J., Wei K., Pendergast W., Gross G.J., et al. ARD-353 [4-((2R,5S)-4-(R)-(4-Diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-d imethylpiperazin-1-ylmethyl)benzoic Acid], a novel nonpeptide {delta} receptor agonist, reduces myocardial infarct size without central effects. J Pharmacol Exp Ther 316 (2006) 423-430
19. Zhang J., Haddad G.G., and Xia Y. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res 885 (2000) 143-153
20. Zhang J., Gibney G.T., Zhao P., and Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol 282 (2002) C1225-C1234
21. Xiong L.Z., Yang J., Wang Q., and Lu Z.H. Involvement of delta- and mu-opioid receptors in the delayed cerebral ischemic tolerance induced by repeated electroacupuncture preconditioning in rats. Chin Med J (Engl) 120 (2007) 394-399
22. Borlongan C.V., Oeltgen P.R., Su T.P., and Wang Y. Delta opioid peptide (DADLE) protects against ischemia-reperfusion damage in the striatum and cerebral cortex. Soc Neurosci Abstr 24 (1999) 979
23. Iwata M., Inoue S., Kawaguchi M., Horiuchi T., and Furuya H. Effect of delta opioid receptor stimulation on global cerebral ischemia in rats. Am Soc Anesthesiolog (2004) A-771
24. Chen W., Yang J.Z., Andersen R., Nielsen L.H., and Borchardt R.T. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model. J Pharmacol Exp Ther 303 (2002) 849-857
25. Zhao P., Huang Y., and Zuo Z. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol 65 (2006) 945-952
26. Hruby V.J., and Gehrig C.A. Recent developments in the design of receptor specific opioid peptides. Med Res Rev 9 (1989) 343-401
27. Pulsinelli W.A., and Brierley J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10 (1979) 267-272
28. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, San Diego
29. Yu W.Z., Ruegg H., and Bodnar R.J. Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucoprivic effects. Pharmacol Biochem Behav 56 (1997) 353-361
30. Kirino T., Tsujita Y., and Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J Cereb Blood Flow Metab 11 (1991) 299-307
31. Zhang Z., Chen T.Y., Kirsch J.R., Toung T.J., Traystman R.J., Koehler R.C., et al. Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats. Anesth Analg 97 (2003) 1776-1783
32. Schultz J.J., Hsu A.K., and Gross G.J. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 29 (1997) 2187-2195
33. Hill M.P., and Brotchie J.M. Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatum. Eur J Pharmacol 281 (1995) R1-R2
34. Gannon R.L., and Terrian D.M. U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals. Brain Res 548 (1991) 242-247
35. MacKay K.B., Patel T.R., Galbraith S.L., Woodruff G.N., and McCulloch J. The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: effect of pretreatment with enadoline (a kappa receptor agonist). Brain Res 712 (1996) 329-334
36. Goyagi T., Toung T.J., Kirsch J.R., Traystman R.J., Koehler R.C., Hurn P.D., et al. Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats. Stroke 34 (2003) 1533-1538
37. Belcheva M.M., Clark A.L., Haas P.D., Serna J.S., Hahn J.W., Kiss A., et al. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J Biol Chem 280 (2005) 27662-27669
38. Huh J., Gross G.J., Nagase H., and Liang B.T. Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 280 (2001) H377-H383
39. Patel H.H., Head B.P., Petersen H.N., Niesman I.R., Huang D., Gross G.J., et al. Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and {delta}-opioid receptors. Am J Physiol Heart Circ Physiol 291 (2006) H344-H350
40. Billet F., Dourmap N., and Costentin J. Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of delta-opioid receptors. Eur J Neurosci 20 (2004) 2629-2638
41. Scherrer G., Befort K., Contet C., Becker J., Matifas A., and Kieffer B.L. The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice. Eur J Neurosci 19 (2004) 2239-2248
42. Fryer R.M., Hsu A.K., and Gross G.J. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 96 (2001) 136-142
43. Patel H.H., Hsu A.K., and Gross G.J. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat. Life Sci 75 (2004) 129-140
44. Heurteaux C., Bertaina V., Widmann C., and Lazdunski M. K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci U S A 90 (1993) 9431-9435
45. Plamondon H., Blondeau N., Heurteaux C., and Lazdunski M. Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels. J Cereb Blood Flow Metab 19 (1999) 1296-1308
46. Lim Y.J., Zheng S., and Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 100 (2004) 562-568
47. Chao D., Bazzy-Asaad A., Balboni G., and Xia Y. delta-, but not mu-, opioid receptor stabilizes K(+) homeostasis by reducing Ca(2+) influx in the cortex during acute hypoxia. J Cell Physiol 212 (2007) 60-67
48. Ma M.C., Qian H., Ghassemi F., Zhao P., and Xia Y. Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem 280 (2005) 16208-16218
49. Narita M., Kuzumaki N., Miyatake M., Sato F., Wachi H., Seyama Y., et al. Role of delta-opioid receptor function in neurogenesis and neuroprotection. J Neurochem 97 (2006) 1494-1505
50. Kiyota Y., Miyamoto M., and Nagaoka A. Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia. Brain Res 538 (1991) 295-302
51. Imamura L., Ohta H., Ni X.H., Matsumoto K., and Watanabe H. Effects of transient cerebral ischemia in gerbils on working memory performance in the delayed nonmatching to position task using a T-maze. Jpn J Pharmacol 57 (1991) 601-608
52. Colbourne F., and Corbett D. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci 15 (1995) 7250-7260
53. Chandler M.J., De Leo J., and Carney J.M. An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes. Journal of Pharmacological Methods 14 (1985) 137-146
54. Wang D., and Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res 533 (1990) 78-82
55. Gulinello M., Lebesgue D., Jover-Mengual T., Zukin R.S., and Etgen A.M. Acute and chronic estradiol treatments reduce memory deficits induced by transient global ischemia in female rats. Horm Behav 49 (2006) 246-260
56. Garcia-Salman J.D., Cordoba-Ramos M., and Cuba-Pena A. Gangliosides prevent reduction in exploratory activity and delayed neuronal death in gerbils subjected to transitory cerebral ischemia. Rev Neurol 27 (1998) 585-588
57. Babcock A.M., Baker D.A., and Lovec R. Locomotor activity in the ischemic gerbil. Brain Res 625 (1993) 351-354
58. Lyden P.D., Lonzo L.M., Nunez S.Y., Dockstader T., Mathieu-Costello O., and Zivin J.A. Effect of ischemic cerebral volume changes on behavior. Behav Brain Res 87 (1997) 59-67
59. Katsuta K., Umemura K., Ueyama N., and Matsuoka N. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils. Eur J Pharmacol 467 (2003) 103-109
60. Andersen M.B., Zimmer J., and Sams-Dodd F. Postischemic hyperactivity in the Mongolian gerbil correlates with loss of hippocampal neurons. Behav Neurosci 111 (1997) 1205-1216
61. Corbett D., and Crooks P. Ischemic preconditioning: a long term survival study using behavioural and histological endpoints. Brain Res 760 (1997) 129-136
62. Gionet T.X., Thomas J.D., Warner D.S., Goodlett C.R., Wasserman E.A., and West J.R. Forebrain ischemia induces selective behavioral impairments associated with hippocampal injury in rats. Stroke 22 (1991) 1040-1047
63. Ishibashi S., Kuroiwa T., LiYuan S., Katsumata N., Li S., Endo S., et al. Long-term cognitive and neuropsychological symptoms after global cerebral ischemia in Mongolian gerbils. Acta Neurochir Suppl 96 (2006) 299-302